No patients had cardiac involvement, but in few cases there was

No patients had cardiac involvement, but in few cases there was a moderate respiratory insufficiency. In all cases CK levels were highly elevated (over 1000 U/L). Discussion The definition of a particularly good level of sporting prowess before the onset of symptoms and the description of a subacute onset with muscle pain and Inhibitors,research,lifescience,medical swelling, if better understood, could potentially help in our understanding of the pathogenesis of the disease. In a group of unselected patients we have tested

the hypothesis whether such sportive activity might influence disease course and progression. Direct clinical comparison with different forms of muscular dystrophy is difficult, since there is no direct match in age of onset and progression. However, when we compared clinical progression of LGMD2B Inhibitors,research,lifescience,medical with LGMD2A, the majority of LGMD2A (20) did not perform Inhibitors,research,lifescience,medical sportive activities, they are not so good at sports or avoided sports at all before

disease onset, and LGMD2A seems to have an indolent atrophic course. Immunosuppressive treatment has been variably tried in LGMD and also in dysferlinopathy patients. While other types of LGMD (LGMD2D, or LGMD2I) have variably responded to steroids, most reports on dysferlin deficiency on steroids are negative and dysferlin deficiency behaves as a refractory disease. In cases of uncertain diagnosis both immunohistological features and western Inhibitors,research,lifescience,medical blotting might help for an accurate diagnosis (17, 21, 22). Also in view of inflammatory cell

in the muscle, the administration of rituximab Inhibitors,research,lifescience,medical has been tried: two patients (23) had some improvement in muscle strength, especially in the isometric hand-grip contraction. To our knowledge, these are the only two cases with increased muscle grip but the report is anedoctical and an opentrial. Furthermore, one of the two patients did not report already any selleck products sustained benefit. IVIg has also been tried with variable efficacy. In our experience, there might be some amelioration due to possible down-regulation of the complement inhibitory factor CD55 but a real controlled trial has not yet been done. Walker and a group of centers in Germany (data presented in Muscular Dystrophy Research Symposium, 2010, Padova) assessed the natural course of disease and efficacy of deflazacort treatment in 25 patients (between 25 and 63 years of age) with genetically confirmed dysferlinopathy in a double-blind, cross-over trial.

We excluded patients who had myocardial infarction,

acute

We excluded patients who had myocardial infarction,

acute inflammatory disease, heart failure, cardiomyopathy, or pericardial effusion. Moreover, we excluded those whose transthoracic echocardiographic view was inadequate for measuring the epicardial fat thickness. On admission, blood sampling was performed to measure total cholesterol, Inhibitors,research,lifescience,medical triglyceride, high density lipoprotein (HDL)-cholesterol, low density lipoprotein (LDL)-cholesterol, fibrinogen and high-sensitivity C-reactive protein (hsCRP) in an overnight fasting state. Height (m2) and body weight (kg) were used to calculated body mass index (BMI). Coronary angiography In a fasting state, coronary angiography was performed by the Judkins’ method following the Perifosine puncture of femoral artery or via a radial artery approach. The severity of coronary atherosclerotic lesions was evaluated from at least Inhibitors,research,lifescience,medical three projections in all the patients. Significant stenosis was defined as a diameter stenosis of 50% or greater in major three epicardial arteries. Blood Inhibitors,research,lifescience,medical sampling for measuring the adiponectin level was obtained at the time of angiography.

Serum adiponectin was measured by ELISA (R&D Systems, Inc., USA). Measurement of echocardiographic cardiac adipose tissue Each patient underwent transthoracic echocardiography on the next day after coronary angiography. Echocardiograms were performed with VIVID 7 (GE, USA) instrument by standard techniques with subjects Inhibitors,research,lifescience,medical in the left lateral decubitus position. We measured EAT thickness on the free wall of right ventricle from

parasternal long-axis views. EAT was identified as an echo-free space in the pericardial layers on the two-dimensional echocardiography and its thickness was measured perpendicularly on the free wall of the right ventricle at end-diastole on three cardiac cycles.13),14) The measurement was performed at the Inhibitors,research,lifescience,medical point on the free wall of the right ventricle along the midline of the ultrasound beam, with the best effort to be perpendicular to the aortic annulus, anatomical landmark (Fig. 1). MAT presenting as an echo-lucent area above the parietal pericardium was also measured at same line. In thin patients whose MAT was indistinguishable, the free wall of the right ventricle was magnified for observation, and if it was still indistinguishable Sodium butyrate after magnification (11 cases), only PAT thickness was used in statistical analysis. The average value of three cardiac cycles from each echocardiographic view was used for the statistical analysis. The intra-observer and inter-observer correlation coefficients were 0.94 and 0.90, respectively, indicating good reproducibility and reliability. Fig. 1 Echocardiographic measurement of epicardial adipose tissue and mediastinal adipose tissue. EAT: epicardial adipose tissue, MAT: mediastinal adipose tissue. Statistics Statistical analysis was done using SPSS 11.0 for Windows.

05 As depicted, if 5% of the controls experience delayed fluid

05. As depicted, if 5% of the controls experience delayed fluid … Assuming a median

survival of around 2 years in control population and ALI increases the risk of death by about 1.25, then the study has 80% power to reject the null hypothesis of equal survival of controls and ALI patients. A target of 100 ALI survivors and 100 controls assuming a standard deviation of the health related quality of life score among ICU patients of 10 units, the study has 80% power to detect a difference in self reported quality of life of 4.0 units or greater. Discussion The LIPS study is a population based observational cohort study that aims to identify patients at high risk Inhibitors,research,lifescience,medical of developing ALI early in the course of illness (at the time of hospital admission), and compare the in-hospital (second hit) exposures and Barasertib ic50 outcomes of patients at high risk who do and do not develop ALI. Analysis and comparison of exposures and outcomes between patients at high risk Inhibitors,research,lifescience,medical identified before ALI development is essential to understand clinical pathogenesis of ALI and design effective prevention strategies.

By determining not only candidate interventions, but also the attributable burden of ALI, it will allow the prioritization of preventive strategies and future clinical trials. Olmsted County offers Inhibitors,research,lifescience,medical a unique opportunity to study

potential ALI prevention targets in a geographically defined population because all the critically ill patients from the county are admitted to Mayo Clinic hospitals. The use of population based sample eliminates the referral bias common in clinical Inhibitors,research,lifescience,medical studies performed at tertiary care institutions[23]. As a part of study design we have developed a near real time Inhibitors,research,lifescience,medical access to pertinent data in electronic medical records to identify patients from the community with or at high risk of ALI. The electronic infrastructure will greatly facilitate to conduct this population based study by minimizing study coordinator time necessary to screen ADP ribosylation factor large number of patients. Time-sensitive biospecimen collection in a population of patients with strictly defined phenotype and detailed capture of environmental exposures will allow for the development of important biospecimen repository for future collaborations in Genome Wide Association and plasma biomarker studies. The principal limitation of our study is imposed by the broad nature and definition of the primary outcome of interest, ALI [21]. The exclusion of left atrial hypertension poses a particular challenge in the clinical assessment of ALI. In addition to using a standardized definition and extensive training of study personnel, all ALI cases will be reviewed by trained expert investigators.

At the present time, our guidelines are created and stored in

At the present time, our guidelines are created and stored in

a format similar to textbooks, serving as a wealth of knowledge but not readily or conveniently accessible. Cardiologists in a busy practice need a means by which they can get their clinical questions answered rapidly from nonbiased trusted sources within their normal work flow to make informed decisions more efficiently and effectively. The ACC and AHA are in the process of creating a system for clinicians to access the “bytes” of knowledge from the ACC/AHA Practice Guidelines. This requires modification of the guidelines into a modular format, allowing the systematic tagging, learn more storage, retrieval and dissemination Inhibitors,research,lifescience,medical of clinical Inhibitors,research,lifescience,medical recommendations. Cardiologists will then be able to obtain pertinent answers to their clinical questions when needed most, at the point of care. Practice Highest-Quality Medicine Current medical practice relies heavily on the unaided mind to recall a great amount of detailed knowledge. This is a process that, to the detriment of all stakeholders, has been repeatedly shown to be unreliable. This unreliability is not just with respect to recall but

also to analysis, processing, and application Inhibitors,research,lifescience,medical to individual patients. It is clear that the individual physician cannot remember all of the details and nuances of a patient’s care. The physician must depend on the system in which he or she practices. This dependence requires that physicians demonstrate the ability to work in a team-based

environment, usually with the responsibility of team leading. Each physician must examine the processes and systems of care with an eye to continuous improvement to assure optimal patient care. An analysis of one’s practice data and Inhibitors,research,lifescience,medical knowledge of the principles of quality improvement are required. All competent physicians should understand the principles of PDSA (plan, do, study, act) or DMAIC (define, measure, analysis, improve, control) formats and continually apply them to improve their systems Inhibitors,research,lifescience,medical of care. Some hospitals and academic medical centers have acquired the ability to analyze their own data through their own databases and electronic health record systems. However, national registries such as the ACC National Cardiovascular Data Registry will play a major role for practicing crotamiton cardiologists who would not otherwise have access to their practice or institutional data. Practice analytics and national quality initiatives authored by professional societies will provide important foundations for continued practice improvement. Practice the Art as Well as the Science of Medicine Patients make choices on the basis of their own values and preferences and not necessarily on the basis of outcomes data, clinical efficiency, or resource implications. Thus, all physicians must be able to understand a patient’s own personal values to make sensible, meaningful, and shared decisions.

8 Because of pharmacokinetic and pharmacodynamic interactions (po

8 Because of pharmacokinetic and pharmacodynamic interactions (potentiation or diminution), severe side effects may be induced or be the reason for absence of response. Better understanding of the principles of clinical pharmacology and education in clinical pharmacology are thus major tasks for the future. The current prescription of psychotropic drugs appears to be well codified for most of the different ICD-10 categories (Table I). Table I. The transnological prescription of antidepressants (AD), neuroleptics (NL), and benzodiazepines (BZD) according to ICD-10 categories (Section V). Clinical treatment with antidepressants Drugs for the treatment of affective

disorders were discovered by serendipity. Imipramine Inhibitors,research,lifescience,medical was found to improve mood while being used in a protocol to search for an antipsychotic:’ Iproniazid, Inhibitors,research,lifescience,medical a drug used in the treatment of tuberculosis, was likewise found to have beneficial effects on mood.9 The former, a tricyclic antidepressant (TCA), and the latter, a monoamine selleck products oxidase inhibitor (MAOI), belong to two classes of drugs still in use today. Depressive mood appears to be attributable to

diminished Inhibitors,research,lifescience,medical activity of the dopaminergic, noradrenergic, and serotonergic neurotransmitter systems. Antidepressants restore the activity of these transmitters by inhibiting reuptake in the presynaptic neurons. Additionally, the classic antidepressants have effects on other neurons (eg, histamine, acetylcholine), resulting in major side effects limiting their broader use. Depressive symptoms have been described in as many as 40 different disorders, which would imply that they could be used in all of them.10 Although the efficacy of TCAs has been well established, the high incidence of side effects Inhibitors,research,lifescience,medical and the high number of nonresponders or treatment-resistant patients represent drawbacks that have made it necessary to search for new drugs. The development of selective serotonin reuptake inhibitors (SSRIs) was the first attempt based on a pathophysiological approach. These drugs, which Inhibitors,research,lifescience,medical have similar efficacy,

but less side effects than the TCAs, have become the preferred pharmacological treatment for depression. However, the high number of nonresponders and the delay in onset of response have limited their value. Some studies claim that they are less effective than TCAs in severe mafosfamide depression.11 Therefore, antidepressants with dual action have been developed. Today, up to seven different classes of antidepressants are available, which mainly differ in their selectivity for the respective monoamines and their receptors.12 These discoveries have intensively stimulated biochemical-pharmacological research into the mechanism of action of antidepressants. Findings from these investigations suggest that enhanced activity of the central noradrenergic and/or serotonergic transmitter system is essential for the clinical antidepressant action.

What is the evidence for impairments of cellular plasticity and r

What is the evidence for impairments of cellular plasticity and resilience in severe mood disorders? Structural imaging studies have demonstrated reduced gray matter volumes in areas of the orbital and medial prefrontal cortex (PFC), ventral striatum, and hippocampus, and enlargement of third ventricle in mooddisordered patients

relative to healthy control Inhibitors,research,lifescience,medical samples.3,9,10 Postmortem neuropathological studies have shown abnormal reductions in glial cell counts/density, neuron size/density, and cortical volume/Selleckchem AZD5363 thickness in the subgenual PFC, orbital cortex, dorsal anterolateral PFC, amygdala, and in basal ganglia and dorsal raphe nuclei and hippocampus.11-16 Morphometric studies also have reported layer-specific reductions Inhibitors,research,lifescience,medical in intern eurons in the anterior cingulate cortex (ACC), and reductions in nonpyramidal neurons (~ 40% lower) in CA2 of the hippocampal

formation in bipolar disorder subjects compared with controls.17 Overall, the layer-specific cellular changes observed in several distinct brain regions, including the PFC, ACC, Inhibitors,research,lifescience,medical and hippocampus suggest that multiple neuronal circuits underlie the neuropathology of mood disorders. This is not altogether surprising since the behavioral and physiological manifestations of the illnesses are complex and include cognitive, affective, motoric, and neurovegetative symptomatology, as well as alterations of circadian rhythms and neuroendocrine systems, and arc thus undoubtedly mediated by networks of interconnected neurotransmitter systems

and neural circuits.13 In addition to the accumulating neuroimaging evidence, several postmortem brain studies are now providing Inhibitors,research,lifescience,medical direct evidence for reductions in regional CNS volume, cell number, and cell body size. Baumann and associates18 reported reduced volumes of the left nucleus accumbens, the right putamen, and bilateral pallidum externum in postmortem brain samples obtained from patients Inhibitors,research,lifescience,medical with unipolar depression or bipolar depression. The abnormal presence of white matter hyperintensities (WMH) has been reported in multiple magnetic resonance imaging (MRI) studies of geriatric patients with affective disorder, particularly those with late-onset depression (ie, elderly depressed patients who experience their first depression after age 60). Elderly adults (>60 years old) with severe WMH are before 3 to 5 times more likely to have depressive symptoms as compared with persons with only mild or no white matter lesions.19 Tupler and colleagues20 reported that late-onset depressed patients had more severe hyperintensity ratings in deep white matter than early-onset patients and controls, and that late- and early-onset patients had more severe subcortical gray matter hyperintensities (particularly in the putamen) compared with controls.

Other areas under investigation for genetic studies include the

Other areas under investigation for genetic studies include the serotononergic and dopaminergic systems. Van Grootheest et al34 studied a large number of twin pairs at age 12, 14, and 16; only at age 14 and 16 were the prevalence higher in girls; genetic factors contributed at all age groups to obsessive-compulsive symptom liability, with no sex differences. Environmental factors shared by children in the same family contribute to symptom score only at age 12. The same group35 studied mono- and dizygotic twin pairs from 8083 families through parental reports on the Inhibitors,research,lifescience,medical Obsessive Compulsive Scale of the Child Behavior Checklist, and

concluded that obsessive-compulsive Inhibitors,research,lifescience,medical behavior is moderately stable in childhood due to genetic, shared, and nonshared environmental factors. Using the same scale, Hudziack et al36 studied 4246 twin pairs and found genetic factors accounting for 55% of the results, with 45% due to environmental influences. Neuroimaging studies In a review article, MacMaster et al37 reported on the results of an extensive

literature search based on imaging techniques such as functional magnetic resonance (fMRI) and voxel-based morphometry, and concluded that the cortical-striatal-thalamic circuits are the most implicated in pediatric OCD. Glutamatergic signals from the frontal Inhibitors,research,lifescience,medical cortex would stimulate striatal activity, diminishing thalamic inhibition. Results Inhibitors,research,lifescience,medical of this meta-analysis included the following findings in youth with OCD: the cingular gyrus was found to be of greater volume and more active, the striatum is diminished, gray matter density in the orbitofrontal cortex is more elevated and voluminous on the right side, and thalamic volume and corpus callosum

are larger. Inhibitors,research,lifescience,medical Evidence from drug therapy studies indicates a role for the dopaminergic (use of atypical antipsychotics), serotoninergic (use of clomipramine and selective serotonin reuptake inhibitors, SSRIs), and glutamatergic (use of riluzole) systems. Lazaro et al38 report on an fMRI study of 12 children with OCD compared with matched subjects; OCD patients presented significantly higher brain activation bilaterally in the middle frontal gyrus with decreased activation in the left insula and putamen after clinical improvement with 6 months of unless pharmacological treatment. MacMaster et al39 studied 28 treatment-naive pediatric OCD patients compared with 21 BI 6727 in vitro controls using magnetic resonance imaging; OCD patients were found to have a larger right orbitofrontal cortex. PANDAS Karla and Swedo40 examined the role of neuroimmune dysfunction in pediatric OCD. As stated, antibody formation may trigger an inflammatory reaction in the basal ganglia following GABHS, as well as possibly other micro-organisms such as viruses, borrelia, and mycoplasma.

Various serotonin probes have been proposed in order to obtain an

Various serotonin probes have been proposed in order to obtain an index of the overall functional status of the central serotonergic system,4 but fenfluramine is the most widely used. Both d-fenfluramine (D-FEN) and the racemate have been used, but the former is a more specific serotonergic probe, lacking the dopaminergic and noradrenergic action of dl-fenfluramine.5,6 D-FEN promotes release and inhibits uptake of serotonin, increasing intrasynaptic levels of the neurotransmitter. This action results in a dose-dependent PD 332991 response of prolactin (PRL) release, which is thought to be mediated by the serotonin (5-hydroxytryptamine, 5-HT) receptors 5-HT2A/5-HT2C7

or by the 5-HT1A Inhibitors,research,lifescience,medical receptors,8 or an interaction between the two. Furthermore, D-FEN was demonstrated to elicit an increase in PRL secretion compared with control (saline) test in patients with Inhibitors,research,lifescience,medical depression, schizophrenia, or personality disorder.9 Thus, a blunted PRL response to D-FEN seems to reflect a deficit in central serotonergic function. There have been many studies of the hormonal response to D-FEN in depressed patients but results are inconsistent. Some authors10-12 found a decreased

PRL response in patients with major depression compared with normal control subjects, but others13,14 could not replicate this finding. However, these studies did not address whether blunted PRL response correlates with Inhibitors,research,lifescience,medical suicidal behavior. Kavoussi et al15 analyzed a sample of outpatients without a history of suicide attempt, and did not find a difference between normal volunteers and depressed patients in PRL response to D-FEN. On the other hand, our previous study16 showed a difference between depressed inpatients and controls, but no clinical Inhibitors,research,lifescience,medical difference was observed between depressed patients with reduced and normal PRL response to D-FEN, except that the former had a history of repeated

suicide attempts. To the best, of our knowledge, there are only two studies comparing the PRL response to D-FEN in patients Inhibitors,research,lifescience,medical with schizophrenia and healthy subjects,17,18 which showed an increased PRL response to D-FEN in the former. Two other studies compared patients with schizophrenia and patients with depression,9,12 showing conflicting results. Whereas Duval et al9 found no else significant difference in the hormonal response to D-FEN between the two groups, Abel et al12 found that PRL, but not Cortisol, response to D-FEN was significantly greater in schizophrenia than in depression. To our knowledge, there have not been any D-FEN studies that specifically address the question of suicidal behavior in schizophrenia. In view of these data, we carried out two studies to test the hypothesis that altered central serotonergic function, as assessed by lower PRL response to D-FEN, is more closely associated with suicidal behavior than to a particular psychiatric diagnosis.

Binbay and colleagues6 prospectively compared short-term quality-

Binbay and colleagues6 prospectively compared short-term quality-of-life scores of 36 patients who were treated with either laparoscopic

selleck chemical radical prostatectomy or open retropubic radical prostatectomy. Different questionnaires were used to assess postoperative quality of life. The study showed that although patients who underwent laparoscopic prostatectomy expressed a more favorable attitude toward surgery in the early period, there was no significant difference in quality of life at 3 months after surgery between the 2 groups. Djavan and coworkers7 presented an update of the European Study on Radical Inhibitors,research,lifescience,medical Prostatectomy. The aim of the study was to evaluate the legacy and impact of preservation of the tip of the seminal vesicle during radical retropubic prostatectomy on potency and continence rates. The investigators concluded that preservation of the tip of the seminal vesicles Inhibitors,research,lifescience,medical significantly

increased post-radical prostatectomy potency rates without jeopardizing oncologic outcomes. T3 Prostate Cancer Prostate cancer patients with locally advanced disease and a PSA value of 20 ng/mL or higher are considered very-high-risk patients. For that reason, most will receive a combination of radiotherapy with hormonal treatment or hormonal Inhibitors,research,lifescience,medical therapy alone. Radical prostatectomy is not considered a valuable treatment option in this patient group. A Belgian study8 evaluated 133 patients with cT3-4N0-1 prostate cancer and a preoperative PSA value of 20 ng/mL or higher who underwent radical surgery at 4 institutions. The results Inhibitors,research,lifescience,medical showed that, in this very select high-risk prostate cancer population,

radical prostatectomy with or without adjuvant Inhibitors,research,lifescience,medical or salvage treatment provided very good long-term cancer-specific survival. The investigators pointed out that radical surgery should not be ignored as a first step in a multimodality approach for very-high-risk prostate cancer. Djavan and coworkers9 evaluated oncologic outcomes of radical prostatectomy and radiotherapy in men with cT3 prostate cancer. The outcome of the study showed clearly that men with cT3 prostate cancer represent a largely inhomogeneous cohort. Disease-specific survival and cancer-specific survival were significantly lower than with cT2 disease. Furthermore, Mannose-binding protein-associated serine protease it was shown that treatment allocation and selection should be made on the basis of Gleason score, PSA value, and age. Age remains an independent and strong predictor of outcome. Interesting conclusions could be found at 5 and 10 years’ follow-up. First, in highly selected men with cT3 prostate cancer, radical prostatectomy offers an effective treatment option. Second, in men with cT3, Gleason score less than 7, and a PSA value of 4 to 10, external beam radiotherapy plus hormonal therapy is equally as effective as radical prostatectomy.

The MS2

The MS2 spectral intensity correlation analysis of the [M - H]- ions at m/z 733 that was degraded suggests a core 2 structure with Fucα1-2Galβ1-3(GlcNAcβ1-6)GalNAc configuration because it gives similar spectra to the spectra reported in the MS2 database UniCarb-DB (Table 1). The drop in intensity

of the [M - H]- ions at m/z 733 after hexosaminidase is due to the degradation of the terminal HexNAc (Figure 3a) generating a core 1 structure terminating in a blood group H epitope (Fucα1-2Galβ1-3GalNAcol) (Figure 3a), which is also supported with spectrum reported in the MS2 database UniCarb-DB (Table 1). Hence, this drop in intensity in core 2 sequence Fucα1-2-Galβ1-3(GlcNAcβ1-6)GalNAcα1-Ser/Thr generating Inhibitors,research,lifescience,medical core 1 sequence confirmed the terminal HexNAc to be β1-6 linked GlcNAc in the structure. C59 wnt price However, the MS2 spectral

correlation Inhibitors,research,lifescience,medical analysis of the [M - H]- ions at m/z 790 with spectra reported in the MS2 database UniCarb-DB suggests that this was a core 2 structure with HexNAc-Galβ1-3(GlcNAcβ1-6)GalNAc configuration (Table 1) with unknown Inhibitors,research,lifescience,medical information about the nature of the HexNAc residue on the C-3 antenna. After hexosaminidase treatment only the C-6 GlcNAc could be removed (Figure 3b). This generated a core 1 structure with one terminal HexNAc still remaining ([M - H]- ions of m/z 587) indicating that the second terminal HexNAc was not in a Inhibitors,research,lifescience,medical β-configuration (Figure 3b), and treatment with the a-N-actetylgalatosaminidase was not successful (data not shown). The MS2 spectral correlation analysis of the [M - H]- ions at m/z 587 suggests a core 1 structure terminated with HexNAc (Table 1) but did not give conclusive result about the configuration (Table 1) when compared with spectra reported in the MS2 database UniCarb-DB. Due to lack of specific enzymes, MS2 of the substrate ([M - H]- ions at m/z 790) and product ([M - Inhibitors,research,lifescience,medical H]- ions at m/z 587) were interpreted manually to investigate the configuration of terminal HexNAc (Figure

3b). Figure 3 (a) Negative ion baseline chromatograms of β-N-acetylhexosaminidase untreated (front) and treated (back) porcine gastric mucin (PGM) oligosaccharides showing the increase of the ions m/z 530 and 587 and a decrease of the m/z 790 and 733 after aminophylline … The identification of cross ring 0,2A fragments of the core 1 GlcNAc residue in the MS2 spectra of the substrate at m/z 790 and the product at m/z 587 (Figure 3b) suggests that this was a terminal HexNAc linked to the 4 position of a Gal because extension to the C-4 provides a diagnostic ion of m/z 304 after loss of water, whereas extension of C-3 does not give this fragment [8]. This indicates that the structure of the substrate ([M - H]- ions at m/z 790) and product ([M - H]- ions at m/z 587) is HexNAc1-4Galβ1-3(GlcNAcβ1-6)GalNAcol and HexNAc1-4Galβ1-3GalNAcol respectively.